Akt is efficiently activated by PIF-pocket- and PtdIns(3,4,5)P3-dependent mechanisms leading to resistance to PDK1 inhibitors
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Akt is efficiently activated by PIF-pocket- and PtdIns(3,4,5)P3-dependent mechanisms leading to resistance to PDK1 inhibitors
Authors
Keywords
-
Journal
BIOCHEMICAL JOURNAL
Volume 448, Issue 2, Pages 285-295
Publisher
Portland Press Ltd.
Online
2012-10-04
DOI
10.1042/bj20121287
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Kinome-wide Selectivity Profiling of ATP-competitive Mammalian Target of Rapamycin (mTOR) Inhibitors and Characterization of Their Binding Kinetics
- (2012) Qingsong Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Discovery of a potent and highly selective PDK1 inhibitor via fragment-based drug discovery
- (2011) Daniel A. Erlanson et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- PDK1 Attenuation Fails to Prevent Tumor Formation in PTEN-Deficient Transgenic Mouse Models
- (2011) K. Ellwood-Yen et al. CANCER RESEARCH
- Targeting PI3K/mTOR Signaling in Cancer
- (2011) B. M. Emerling et al. CANCER RESEARCH
- Structure-Based Design of Potent and Selective 3-Phosphoinositide-Dependent Kinase-1 (PDK1) Inhibitors
- (2011) Jesús R. Medina et al. JOURNAL OF MEDICINAL CHEMISTRY
- Characterization of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1)
- (2010) Laura R. Pearce et al. BIOCHEMICAL JOURNAL
- Characterization of GSK2334470, a novel and highly specific inhibitor of PDK1
- (2010) Ayaz Najafov et al. BIOCHEMICAL JOURNAL
- Functions and regulation of the 70kDa ribosomal S6 kinases
- (2010) Tim R. Fenton et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Discovery of PDK1 Kinase Inhibitors with a Novel Mechanism of Action by Ultrahigh Throughput Screening
- (2010) Ekaterina V. Bobkova et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Regulation of 3-Phosphoinositide-Dependent Protein Kinase 1 Activity by Homodimerization in Live Cells
- (2010) T. A. Masters et al. Science Signaling
- Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR)
- (2009) Juan M. García-Martínez et al. BIOCHEMICAL JOURNAL
- AKT-Independent Signaling Downstream of Oncogenic PIK3CA Mutations in Human Cancer
- (2009) Krishna M. Vasudevan et al. CANCER CELL
- AZD8055 Is a Potent, Selective, and Orally Bioavailable ATP-Competitive Mammalian Target of Rapamycin Kinase Inhibitor with In vitro and In vivo Antitumor Activity
- (2009) C. M. Chresta et al. CANCER RESEARCH
- The nuts and bolts of AGC protein kinases
- (2009) Laura R. Pearce et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer
- (2009) Simon A. Forbes et al. NUCLEIC ACIDS RESEARCH
- mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1)
- (2008) Juan M. García-Martínez et al. BIOCHEMICAL JOURNAL
- Small-Molecule Inhibitors of PDK1
- (2008) Christian Peifer et al. ChemMedChem
- Mutation of the PDK1 PH Domain Inhibits Protein Kinase B/Akt, Leading to Small Size and Insulin Resistance
- (2008) J. R. Bayascas et al. MOLECULAR AND CELLULAR BIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started